AdamScottKittaiMD

PubMed

• An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL.
  John N Allan, Dan James, Helen Bridge, Miguel Miranda, Alan Sm Yong, Fady Fam, Jack Roos, Vikram Shetty Dr, Adam S Kittai, Alan P Skarbnik, Matthew S Davids> ;Blood Advances. 2024 Apr 10
• Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
  Adam S Kittai, Ying Hang, Seema A Bhat, Abi Clark, Michael Grever, Joanna M Rhodes, Melyssa Roberts, Kerry A Rogers, Anna Teschemaker, Maria Munoz-Sagastibelza, Jennif...> ;American Journal of Hematology. 2024 Apr 1
• Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
  Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth, John C Byrd, Julio C Chavez, Matthew S Davids, Jamie P Dela Cruz, Mark R Dowling, Caitlyn Duffy, Carr...> ;Journal of Clinical Oncology. 2024 Mar 29
• Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
  Voorhees, T. J., Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert Bolz, Jessica Miao, Chunhua Song, Day...> ;Blood Advances. 2024 Mar 23
• Comparison of karyotype scoring guidelines for evaluating karyotype complexity in chronic lymphocytic leukemia.
  Avenarius, M., Huang, Y., Miller, C., Kittai, A., Bhat, S., Rogers, K., Grever, M., Woyach, J.> ;Leukemia. 2024 Mar 1
• Treatment of Richter's Transformation with Novel Therapies.
  Habib, A., Bajwa, A., Kittai, A.> ;Current Hematologic Malignancy Reports. 2024 Apr 1
• Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
  Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M Stephens, Catherine J Lee, Thomas Ollila, Geoffrey Shouse, Alexey V Danilov, Ke...> ;Journal of Hematology & Oncology. 2023 Nov 9
• Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
  Samantha M Teierle, Ying Huang, Adam S Kittai, Seema A Bhat, Michael Grever, Kerry A Rogers, Weiqiang Zhao, Daniel Jones, John C Byrd, Matthew R Avenarius, Nyla A Heer...> ;Blood Advances. 2023 Dec 12
• 1 citations
  A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia.
  Adam S Kittai, Alan Skarbnik, Miguel Miranda, Alan S M Yong, Jack Roos, Robert Hettle, Sarah Palazuelos-Munoz, Vikram Shetty, Paolo Ghia> ;American Journal of Hematology. 2023 Dec 1
• Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy.
  Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, J...> ;Leukemia. 2023 Jul 1
• TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma.
  Max J Gordon, David A Bond, Adam S Kittai, Neda Amirmokhtari, Abigail Steinbrunner, Allison Huffman, Victor Orellana-Noia, Geoffrey Shouse, Jonathon B Cohen, Tycel Phi...> ;Haematologica. 2023 Nov 1
• Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
  Matthew R Avenarius, Ying Huang, Jonathan Hyak, John C Byrd, Seema A Bhat, Michael Grever, Adam S Kittai, Kerry A Rogers, Dan Jones, Weiqiang Zhao, Nyla A Heerema, Lyn...> ;Hematological Oncology. 2023 Oct 1
• 1 citations
  Evaluation of bleeding events in patients receiving acalabrutinib therapy.
  Pooja S Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C Byrd, Michael R Grever, Kerry A Rogers, J...> ;Leukemia. 2023 Jul 1
• 4 citations
  Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
  Benjamin Buck, Aaron P Chum, Mitkumar Patel, Rebecca Carter, Haseeb Nawaz, Vedat Yildiz, Patrick Ruz, Tracy Wiczer, Kerry A Rogers, Farrukh T Awan, Seema Bhat, Avirup ...> ;JAMA Oncology. 2023 Apr 1
• 23 citations
  Ventricular arrhythmias and sudden death events following acalabrutinib initiation.
  Seema A Bhat, John Gambril, Leylah Azali, Sunnia T Chen, Lindsay Rosen, Marilly Palettas, Tracy E Wiczer, Sujay Kalathoor, Qiuhong Zhao, Kerry A Rogers, Adam Kittai, M...> ;Blood. 2022 Nov 17
• Glabellar and auricular leukemia cutis in CLL.
  Bradley Steinman, Jose A Plaza, Adam S Kittai> ;Ejhaem. 2022 Nov 1
• 6 citations
  Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.
  Chia Sharpe, J Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik, Xiaokui Mo, Jennifer A Woyach, Deepa Sampath, Adam S Kittai, Sumithira Vasu, Seema Bhat, Kerry A Roge...> ;Blood Advances. 2022 Oct 25
• 11 citations
  Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
  Sophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, Rozbeh Jafari, Ioannis Siavelis, Matthias Stahl, Eva C Schitter, Nora Liebers, Berit J Brinkmann, Felix Cze...> ;Nature Communications. 2022 Oct 20
• 6 citations
  Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
  Adam S Kittai, Ying Huang, Kyle A Beckwith, Seema A Bhat, David A Bond, John C Byrd, Daniel Goldstein, Michael R Grever, Cecelia Miller, Kerry A Rogers, Jennifer A Woy...> ;American Journal of Hematology. 2023 Jan 1
• 5 citations
  Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.
  Jonathan M Hyak, Ying Huang, Kerry A Rogers, Seema A Bhat, Michael R Grever, John C Byrd, Adam S Kittai, Dan Jones, Cecelia R Miller, Jennifer A Woyach> ;Blood Advances. 2022 Sep 13
• 10 citations
  Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
  Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin David, Jonathon B Cohen, Tamara K Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sa...> ;Blood Advances. 2023 Jun 27
• 4 citations
  Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019.
  Adam S Kittai, Ying Huang, Seema A Bhat, Electra D Paskett, Kerry A Rogers, Jacqueline C Barrientos, James L Fisher, Jennifer A Woyach> ;Blood Advances. 2023 Jun 13
• 1 citations
  uMRD: "the" endpoint or "an" endpoint for CLL?
  Adam S Kittai, Jennifer A Woyach> ;Blood. 2022 Aug 25
• 6 citations
  Richter's Transformation.
  Audrey M Sigmund, Adam S Kittai> ;Current Oncology Reports. 2022 Aug 1
• 3 citations
  Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib.
  Audrey M Sigmund, Ying Huang, Amy S Ruppert, Kami Maddocks, Kerry A Rogers, Samantha Jaglowski, Seema A Bhat, Adam S Kittai, Michael R Grever, John C Byrd, Jennifer A ...> ;Leukemia. 2022 Aug 1
• Join now to see all

Abstracts/Posters

• Neddylation Pathway Regulates Treg Differentiation and T Cell Function in Chronic Lymphocytic Leukemia (CLL) Ex Vivo and Murine In Vivo Studies
  Adam S. Kittai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comorbidities Predict Inferior Survival in Patients Receiving CAR T-Cell Therapy for Relapsed/Refractory DLBCL: A Multicenter Retrospective Analysis
  Adam S. Kittai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
  Adam S. Kittai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• SYK Inhibitor Entospletinib in Combination with Obinutuzumab Demonstrates Efficacy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Pevonedistat, a Small Molecule Inhibitor of NEDD8-Activating Enzyme (NAE), Induces Cell Cycle Deregulation, Anaphase Catastrophe, and Apoptosis in T-Cell Lymphoma Cells 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018